Sigyn Therapeutics, Inc. (SIGY)

Sigyn Therapeutics Cash Flow Statement

Financials in millions USD. Fiscal year is January - December.

Year	2023	2022	2021	2020	2019	2018	2017	2016	2015	2014
Net Income	-4.15	-3.71	-3.4	-1.6	-3.13	-2.62	-4.25	-0.83	-2.69	-0.39
Depreciation & Amortization	0.01	0.01	0.02	0.01	0.08	0.25	0.24	0.09	0	0
Share-Based Compensation	0.22	0	0	0	0	0.01	0.06	0	1.4	0
Other Operating Activities	2.54	1.87	1.61	0.76	2.91	2.08	3.55	0.61	1.21	0.34
Operating Cash Flow	-1.38	-1.83	-1.77	-0.83	-0.14	-0.29	-0.4	-0.13	-0.08	-0.04
Capital Expenditures	0	-0	-0.03	-0.01	0	-0.01	-0.08	-0.12	-0.01	-0
Acquisitions	0	0	0	0	0.1	0	0	0	0	0
Investing Cash Flow	0	-0	-0.03	-0.01	0.1	-0.01	-0.08	-0.12	-0.01	-0
Common Stock Issued	1.52	0.15	1.87	0.4	0	0.21	0	0.2	0	0
Other Financing Activities	-0.13	1.35	0.2	0.53	0.04	0.09	0.34	0.01	0.74	0.05
Financing Cash Flow	1.39	1.5	2.06	0.93	0.04	0.29	0.34	0.21	0.74	0.05
Net Cash Flow	0	-0.33	0.26	0.08	-0.01	-0	-0.14	-0.19	0.64	0
Free Cash Flow	-1.38	-1.83	-1.8	-0.84	-0.14	-0.29	-0.48	-0.25	-0.1	-0.05
Free Cash Flow Margin	-	-	-	-	-100.25%	-1039.10%	-37.31%	-13.81%	-329.62%	-111.01%
Free Cash Flow Per Share	-1.26	-0.05	-0.05	-0.11	-0.27	-0.68	-1.53	-34.44	-0.42	-0.26

Sources: The data provider is Financial Modeling Prep and the numbers are sourced from SEC filings.